Clinical Report: Coagulation Indicators in Acute Fatty Liver During Pregnancy
Overview
This study evaluates coagulation indicators in 92 patients with Acute Fatty Liver of Pregnancy (AFLP) and their association with adverse outcomes. It identifies INR and PT as strong predictors of disease severity, highlighting their potential role in clinical decision-making.
Background
Acute Fatty Liver of Pregnancy (AFLP) is a rare but serious condition that can lead to significant maternal and fetal morbidity and mortality. Coagulation dysfunction is a critical feature of AFLP, complicating the management and increasing the risk of adverse events. Understanding the relationship between coagulation indicators and clinical outcomes is essential for improving risk assessment and timely intervention.
Data Highlights
Indicator
AUC
INR
0.837
PT
0.837
Key Findings
INR and PT showed the strongest predictive performance for adverse outcomes in AFLP.
The VIF value of PT indicated severe multicollinearity, while INR was independently associated with higher rates of MODS and DIC.
Coagulation dysfunction is an early feature of AFLP, driven by hepatic impairment and systemic inflammation.
ICU admission serves as a surrogate for severe disease but is influenced by clinician judgment.
Improved risk stratification using INR may support clinical decision-making in AFLP management.
Clinical Implications
Healthcare professionals should consider INR and PT as key indicators for assessing the severity of AFLP. Early identification of coagulation dysfunction can facilitate timely interventions and improve maternal and fetal outcomes.
Conclusion
Coagulation indicators, particularly INR, are crucial in predicting adverse outcomes in AFLP. Further validation of these findings is needed before routine clinical application.
